Delphine Vimont

Evaluation of 68Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1

Clément Morgat, Fritz‐Line Vélayoudom‐Céphise, Paul Schwartz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 51 citations

Positron Emission Tomography, Neuro-oncology, 68Ga-dota-toc Pet/ct +9

Comparison of⁶⁸Ga-PSMA-617 PET/CT and⁶⁸Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study

Romain Schollhammer, G. Robert, Julien Asselineau et al. · Journal of Nuclear Medicine · 2022 · 45 citations · Full text

Silicon‐Based Chemistry: An Original and Efficient One‐Step Approach to [¹⁸F]‐Nucleosides and [¹⁸F]‐Oligonucleotides for PET Imaging

Jürgen Schulz, Delphine Vimont, Thomas Bordenave et al. · Chemistry - A European Journal · 2011 · 38 citations

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples

Clément Morgat, Romain Schollhammer, Gaëtan MacGrogan et al. · PLoS ONE · 2019 · 36 citations · Full text

Breast Oncology, Oncologic Imaging, 18F-fdg Binding +21

Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples

Romain Schollhammer, Henri de Clermont Gallerande, Mokrane Yacoub et al. · EJNMMI Research · 2019 · 36 citations · Full text